Indian Science Abstracts
Author :
Publisher :
Page : 1148 pages
File Size : 35,67 MB
Release : 1992
Category : Science
ISBN :
Author :
Publisher :
Page : 1148 pages
File Size : 35,67 MB
Release : 1992
Category : Science
ISBN :
Author : Great Britain: Parliament: House of Commons: Health Committee
Publisher : The Stationery Office
Page : 556 pages
File Size : 33,32 MB
Release : 2005-04-26
Category : Political Science
ISBN : 9780215024572
Incorporating HC 1030-i to iii.
Author : 3M Company
Publisher : 3m Company
Page : 246 pages
File Size : 11,98 MB
Release : 2002
Category : 3M Company
ISBN :
A compilation of 3M voices, memories, facts and experiences from the company's first 100 years.
Author :
Publisher :
Page : 832 pages
File Size : 23,62 MB
Release : 1992
Category : Conference proceedings
ISBN :
Author : American College of Physicians
Publisher : ACP Press
Page : 340 pages
File Size : 42,32 MB
Release : 2008
Category : Medical
ISBN : 9781934465035
Designed for medical students on their clerkship rotation, this new edition of MKSAP for Students 4 includes more than 400 new, patient-centered self-assessment questions and answers, focused on important internal medicine information from the Core Medicine Clerkship Curriculum Guides Training Problems. The accompanying CD-ROM automatically tracks progress, assesses areas for further focus, enables category-based and random question ordering, and links directly to PubMed.
Author : Sarah E. Boslaugh
Publisher : SAGE Publications
Page : 3157 pages
File Size : 13,2 MB
Release : 2015-09-15
Category : Health & Fitness
ISBN : 1506346189
The SAGE Encyclopedia of Pharmacology and Society explores the social and policy sides of the pharmaceutical industry and its pervasive influence in society. While many technical STM works explore the chemistry and biology of pharmacology and an equally large number of clinically oriented works focus on use of illegal drugs, substance abuse, and treatment, there is virtually nothing on the immensely huge business (“Big Pharma”) of creating, selling, consuming, and regulating legal drugs. With this new Encyclopedia, the topic of socioeconomic, business and consumer, and legal and ethical issues of the pharmaceutical industry in contemporary society around the world are addressed. Key Features: 800 signed articles, authored by prominent scholars, are arranged A-to-Z and published in a choice of electronic or print formats Although arranged A-to-Z, a Reader's Guide in the front matter groups articles by thematic areas Front matter also includes a Chronology highlighting significant developments in this field All articles conclude with Further Readings and Cross References to related articles Back matter includes an annotated Resource Guide to further research, a Glossary, Appendices (e.g., statistics on the amount and types of drugs prescribed, etc.), and a detailed Index The Index, Reader’s Guide, and Cross References combine for search-and-browse capabilities in the electronic edition The SAGE Encyclopedia of Pharmacology and Society is an authoritative and rigorous source addressing the pharmacology industry and how it influences society, making it a must-have reference for all academic libraries as a source for both students and researchers to utilize.
Author : Mahmoud Ghannoum
Publisher : CRC Press
Page : 484 pages
File Size : 34,78 MB
Release : 2016-04-19
Category : Medical
ISBN : 0849387868
A concise one-stop-practical reference for the various physicians dealing with fungal infections, Antifungal Therapy appeals to infectious disease physicians, transplant surgeons, dermatologists, and intensivists, as well as basic scientists and pharmaceutical company researchers interested in the state of antifungal therapy. This book provides a c
Author : Carl J. Dahlman
Publisher : World Bank Publications
Page : 216 pages
File Size : 27,4 MB
Release : 2005-01-01
Category : Computers
ISBN : 0821362089
"In the global knowledge economy of the twenty-first century, India's development policy challenges will require it to use knowledge more effectively to raise the productivity of agriculture, industry, and services and reduce poverty. India has made tremendous strides in its economic and social development in the past two decades. Its impressive growth in recent years-8.2 percent in 2003-can be attributed to the far-reaching reforms embarked on in 1991 and to opening the economy to global competition. In addition, India can count on a number of strengths as it strives to transform itself into a knowledge-based economy-availability of skilled human capital, a democratic system, widespread use of English, macroeconomic stability, a dynamic private sector, institutions of a free market economy; a local market that is one of the largest in the world; a well-developed financial sector; and a broad and diversified science and technology infrastructure, and global niches in IT. But India can do more-much more-to leverage its strengths and grasp today's opportunities. India and the Knowledge Economy assesses India's progress in becoming a knowledge economy and suggests actions to strengthen the economic and institutional regime, develop educated and skilled workers, create an efficient innovation system, and build a dynamic information infrastructure. It highlights that to get the greatest benefits from the knowledge revolution, India will need to press on with the economic reform agenda that it put into motion a decade ago and continue to implement the various policy and institutional changes needed to accelerate growth. In so doing, it will be able to improve its international competitivenessand join the ranks of countries that are making a successful transition to the knowledge economy."
Author : W. Schönfeld
Publisher : Springer Science & Business Media
Page : 344 pages
File Size : 20,58 MB
Release : 2002-03-01
Category : Medical
ISBN : 9783764361860
There are only very few chemical classes of antibiotics in medical use, and these have originated over a span of more than 60 years of research. Almost half a century ago, the first member of the macrolides, erythromycin, was introduced as a treatment option for bacterial infections. Erythromycin is a very complex fermentation product obtained from the soil bacterium Saccharopolyspora ery thraea (originally named Streptomyces erythreus). The success of erythromycin, based on its efficacy and tolerability, stimulated researchers throughout the world to undertake intense efforts to understand the biology and chemistry of macrolides and to use this experience to improve the properties of this compound class. The second generation of macrolides, based on chemical modifications of erythromy cin, is currently being in broad use, especially for treatment of respiratory tract infections. We presently foresee the introduction of a new generation of macro lides, i. e. the ketolides, which have the potential to overcome rising resistance problems. This monograph is intended to give the interested reader an overview on "macrolide experience", covering important areas from basic research to clinical use. Starting from a historic overview, the essential basic parameters - efficacy, pharmacokinetics, pharmacodynamics, and pharmacology - are highlighted in order to introduce the reader to the rationale for clinical use of macrolides. The following group of chapters cover the complex chemistry of the macro lactone structures, giving historic background, basic structure-activity relation ships of various derivatization strategies, and perspectives for future discovery of new semisynthetic macrolide antibiotics.
Author :
Publisher :
Page : 56 pages
File Size : 25,77 MB
Release : 1994
Category : Communicable diseases
ISBN :
This plan addresses the need to improve our ability to identify infectious disease threats and respond to them effectively by improving the public health infrastructure at the local, state and federal levels. The goals of the plan are surveillance (detect, promptly investigate, and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence); applied research (integrate laboratory science and epidemiology to optimize public health practice); prevention and control (enhance communication of public health information about emerging diseases and ensure prompt implementation of prevention strategies); and infrastructure (strengthen local, state, and federal public health infrastructures to support surveillance and implement prevention and control programs).